Homevideos Newsmarket News

    Moneycontrol Pro Ideas For Profit: Here’s why Gland Pharma is in focus

    videos | IST

    Moneycontrol Pro Ideas For Profit: Here’s why Gland Pharma is in focus

    Mini

    Gland Pharma reported strong third quarter earnings with expected normalisation of margins. There have been concerns over valuations, but one has to give due credence to the impeccable regulatory compliance history of Gland Pharma.

    Gland Pharma reported strong third quarter earnings with expected normalisation of margins. There have been concerns over valuations, but one has to give due credence to the impeccable regulatory compliance history of Gland Pharma.
    Moneycontrol.com’s Anubhav Sahu gets more details on the stock’s performance in the special segment ‘Moneycontrol Pro Ideas For Profit’.
    Watch the video for more
    Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
    next story

      Most Read

      Market Movers

      View All
      CompanyPriceChng%Chng